“…The disease biomarkers are often detected at all stages during diseases diagnostic and treatment, while such detection remains a challenge currently [3,4]. Molecular imaging enables visualization of disease biomarkers and their metabolisms in living systems in real time at various levels from molecules and single cells, to tissues, and organs, which allows detection and differential diagnosis of diseases [5,6]. Over the past decades, a variety of molecular imaging techniques, such as positron emission tomography (PET), X-ray computed tomography (CT), magnetic resonance imaging (MRI) and fluorescence imaging (FI), have been widely used in clinical diagnostics, biomedical research and molecular imaging fields [7,8,9,10].…”